https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html
Data Table
Location | B.1.1.529 Variant Cases 12/18 |
---|---|
Alabama | Yes |
Alaska | Yes |
American Samoa | No |
Arizona | Yes |
Arkansas | Yes |
California | Yes |
Colorado | Yes |
Connecticut | Yes |
Delaware | No |
Florida | Yes |
Georgia | Yes |
Guam | No |
Hawaii | Yes |
Idaho | Yes |
Illinois | Yes |
Indiana | No |
Iowa | Yes |
Kansas | Yes |
Kentucky | Yes |
Louisiana | Yes |
Maine | Yes |
Marshall Islands | No |
Maryland | Yes |
Massachusetts | Yes |
Michigan | Yes |
Micronesia | No |
Minnesota | Yes |
Mississippi | Yes |
Missouri | Yes |
Montana | No |
Nebraska | Yes |
Nevada | Yes |
New Hampshire | Yes |
New Jersey | Yes |
New Mexico | Yes |
New York | Yes |
North Carolina | Yes |
North Dakota | No |
Northern Marianas | No |
Ohio | Yes |
Oklahoma | No |
Oregon | Yes |
Palau | No |
Pennsylvania | Yes |
Puerto Rico | Yes |
Rhode Island | Yes |
South Carolina | Yes |
South Dakota | No |
Tennessee | Yes |
Texas | Yes |
Utah | Yes |
Vermont | No |
Virgin Islands | No |
Virginia | Yes |
Washington | Yes |
Washington D.C. | Yes |
West Virginia | Yes |
Wisconsin | Yes |
Wyoming | Yes |
There are two variants classified as a VOC by the United States: Omicron and Delta. As of December 2, 2021, two confirmed cases attributed to the Omicron variant have been detected in the United States and additional possible Omicron cases are being investigated. Delta continues to be the predominant circulating variant.
On August 26, 2021, CDC published information on What We Know About the Delta Variant.
Importantly, nearly all lineages designated as Delta remain susceptible to available monoclonal antibody therapeutics, and vaccines continue to be highly effective against severe illness, hospitalization, and death among people infected with the Delta variant.
What We Know about Omicron
Infection and Spread
- How easily does Omicron spread? The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus and how easily Omicron spreads compared to Delta remains unknown. CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms.
- Will Omicron cause more severe illness? More data are needed to know if Omicron infections, and especially reinfections and breakthrough infections in people who are fully vaccinated, cause more severe illness or death than infection with other variants.
- Will vaccines work against Omicron? Current vaccines are expected to protect against severe illness, hospitalizations, and deaths due to infection with the Omicron variant. However, breakthrough infections in people who are fully vaccinated are likely to occur. With other variants, like Delta, vaccines have remained effective at preventing severe illness, hospitalizations, and death. The recent emergence of Omicron further emphasizes the importance of vaccination and boosters.
- Will treatments work against Omicron? Scientists are working to determine how well existing treatments for COVID-19 work. Based on the changed genetic make-up of Omicron, some treatments are likely to remain effective while others may be less effective.
OVID-19 cases, deaths and hospitalizations have all surged in the country, with many parts experiencing high levels of community transmission, according to the U.S. Centers for Disease Control and Prevention (CDC).
The current daily average of COVID-19 cases is about 128,000, a 17-percent increase in the last 14 days. https://www.nytimes.com/interactive/2021/us/covid-cases.html
The average daily deaths is about 1,296, up 9 percent from the prior 14 days.
On the 17th of December, a total of 62,616 Americans are in hospital due to COVID-19. https://ourworldindata.org/grapher/current-covid-patients-hospital?country=USA
The latest data emerging from the U.S. NIH and U.S.CDC are that 6,321 new COVID-19 hospitalizations were recorded in the last 24 hours.
As of the 18th of December, a total of 16,052 Americans are in ICU due to COVID-19.
The U.S. CDC is merely saying that the Omicron variant represents about 3% to 3.5% of COVID samples analyzed in the U.S.
Full breakdowns like that in Europe are not being provided.
https://www.ecdc.europa.eu/en/news-events/epidemiological-update-omicron-data-16-december
Table. Confirmed SARS-CoV-2 Omicron VOC cases reported by public sources, as of 16 December 2021 (12:00)
Country/Region | Confirmed cases |
---|---|
EU/EEA Total | 3 158 |
Austria | 71 |
Belgium | 121 |
Croatia | 8 |
Cyprus | 3 |
Czechia | 10 |
Denmark | 383* |
Estonia | 6 |
Finland | 34 |
France | 170 |
Germany | 102 |
Greece | 10 |
Hungary | 2 |
Iceland | 40 |
Ireland | 42 |
Italy | 27 |
Latvia | 14 |
Liechtenstein | 2 |
Lithuania | 2 |
Luxembourg | 1 |
Netherlands | 123 |
Norway | 1 792** |
Portugal | 69 |
Romania | 11 |
Slovakia | 3 |
Slovenia | 10 |
Spain | 51 |
Sweden | 51 |
* Denmark reported 383 cases as confirmed through whole genome sequencing and 5 664 as confirmed nationally through a variant-specific PCR.
** Norway announced that probable cases of Omicron VOC infection are now considered as confirmed cases and, therefore, the total number of Omicron detections included for Norway in this report consists of both probable and confirmed cases.
Despite the increased attention for Omicron, Delta continues to be the main variant circulating in the United States. For the week ending Dec. 11, the Delta variant accounted for 96.7 percent of circulating SARS-CoV-2 variants, according to the U.S.CDC.
However, what the U.S. CDC stopped short of mentioning was that a variety of new Delta subvariants are at play here and some are even more concerning than the Omicron as they too are causing breakthrough infections but once again the Biden administration is suppressing such data.
Heavy holiday travel has already begun amid Omicron concerns. The U.S. Transportation Security Administration expected up to 21 million Americans will fly between Dec. 23 and Jan. 3. These travel traffic will help to spread the virus even more.
Co-infections with two variants or more are expected to be a new common phenomenon soon in the United States just like in the UK and more worrisome variants are expected to emerge as a result of recombinant events.